2021 Pharmaceutical Contract Manufacturing Industry Mergers and Acquisitions Report: Supplier Performance Benchmarking, Market Trends, Competitive Intelligence

DUBLIN, July 16, 2021 /PRNewswire/ — The “Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry – Implications and Outlook – 2021 Edition” report has been added to’s offering.

Research and Markets Logo

This report is the third edition of our analysis of mergers and acquisitions in the pharmaceutical contract manufacturing industry.

This report gives important, expert insight you won’t find in any other source. 28 tables and figures throughout the report illustrate major points and trends.


This report is required reading for:

  • CMOs: market trends, strategic planning, competitive intelligence, performance benchmarking
  • Bio/Pharma: supplier performance benchmarking, market trends, competitive intelligence
  • Private equity and Stock analysts: target identification and analysis, portfolio company performance benchmarking

Reasons to Buy

  • Overview of M&A in the Pharma CMO Industry
  • Detailed view of CDMO performance by number of deals completed from the publisher’s Deals database
  • Analysis of the M&A of specific manufacturing services

Key Topics Covered:

Executive Summary

  • Players
  • Trends

Industry Analysis

  • Objectives and Methodology
  • Overview of M&A Activity 2018-2020
  • Target Characteristics
  • Acquirer Characteristics
  • Geography
  • Top Acquirers

Segment Close-Ups of M&A Activity, 2018-2020

  • API-Biologic
  • API-Small Molecule
  • Commercial Dose Manufacturing
  • Analytical Services
  • Packaging
  • Deal Advisors
  • Top Financial Advisors
  • Top Legal Advisors


  • Facility Acquisitions
  • What It Means
  • The Outlook for M&A
  • API-Biologic Targets
  • Past Predictions
  • Value Chain
  • Companies


For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Cision View original content:

SOURCE Research and Markets

Written by Tenner Smith

Tenner Smith - I have experience in financial intelligence and automated intelligence. In industry I have worked on artificial intelligence and machine learning. Tenner Smith is a reporter at DF media.

ServiceMax, a Leader in Field Service Management SaaS, to Be Listed on Nasdaq following Business Combination with Pathfinder Acquisition Corporation

CCIV ALERT: GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Churchill Capital Corp IV Investors with Losses Over $250K to Secure Counsel Before August 30 Deadline in Securities Class Action – CCIV